Cargando…

TNNI3K, a Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy in Transgenic Mice

PURPOSE: Protein kinase plays an essential role in controlling cardiac growth and hypertrophic remodeling. The cardiac troponin I-interacting kinase (TNNI3K), a novel cardiac specific kinase, is associated with cardiomyocyte hypertrophy. However, the precise function of TNNI3K in regulating cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaojian, Wang, Jizheng, Su, Ming, Wang, Changxin, Chen, Jingzhou, Wang, Hu, Song, Lei, Zou, Yubao, Zhang, Lianfeng, Zhang, Youyi, Hui, Rutai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589374/ https://www.ncbi.nlm.nih.gov/pubmed/23472207 http://dx.doi.org/10.1371/journal.pone.0058570

Ejemplares similares

mTOR pathway in human cardiac hypertrophy caused by LEOPARD syndrome: a different role compared with animal models?
por: Cui, Hao, et al.
Publicado: (2019)

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
por: Wang, Hui, et al.
Publicado: (2013)

The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment
por: Pham, Caroline, et al.
Publicado: (2021)

New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
por: Asquith, Christopher R. M., et al.
Publicado: (2020)

Identification of a nonsense mutation in TNNI3K associated with cardiac conduction disease
por: Liu, Jiang, et al.
Publicado: (2020)

Tnni1b-ECR183-d2, an 87 bp cardiac enhancer of zebrafish
por: Zhang, Yawen, et al.
Publicado: (2020)

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1
por: Song, Lei, et al.
Publicado: (2014)

Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways
por: Gu, Qingqing, et al.
Publicado: (2023)

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency
por: Gan, Peiheng, et al.
Publicado: (2019)

The role of K63‐linked polyubiquitination in cardiac hypertrophy
por: Yan, Kaowen, et al.
Publicado: (2018)

Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
por: Lodder, Elisabeth M., et al.
Publicado: (2012)

A Novel Missense Mutation in TNNI3K Causes Recessively Inherited Cardiac Conduction Disease in a Consanguineous Pakistani Family
por: Ramzan, Shafaq, et al.
Publicado: (2021)

Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
por: Wheeler, Ferrin C., et al.
Publicado: (2009)

Energy Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy
por: Xiang, Kefa, et al.
Publicado: (2020)

Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy
por: An, Xiangbo, et al.
Publicado: (2016)

Genome-wide expression patterns in physiological cardiac hypertrophy
por: Drozdov, Ignat, et al.
Publicado: (2010)

The role of Hippo signaling pathway in physiological cardiac hypertrophy
por: Gholipour, Majid, et al.
Publicado: (2020)

GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model
por: Hu, Xiaoqing, et al.
Publicado: (2011)

A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)
por: Pantou, Malena P., et al.
Publicado: (2019)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways
por: Song, Yao, et al.
Publicado: (2012)

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
por: Wang, Jian, et al.
Publicado: (2012)

Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene
por: Chen, Yan, et al.
Publicado: (2014)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy
por: Cui, Hao, et al.
Publicado: (2018)

TNNI1 Mutated in Autosomal Dominant Proximal Arthrogryposis
por: Nishimori, Yukako, et al.
Publicado: (2021)

Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

Rare Variants in Genes Encoding MuRF1 and MuRF2 Are Modifiers of Hypertrophic Cardiomyopathy
por: Su, Ming, et al.
Publicado: (2014)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

AMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy
por: Lipovka, Yulia, et al.
Publicado: (2015)

The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension
por: Wang, Yuyao, et al.
Publicado: (2015)

Senescence as a novel mechanism involved in β-adrenergic receptor mediated cardiac hypertrophy
por: Sun, Rongrong, et al.
Publicado: (2017)

Actin-Binding Proteins in Cardiac Hypertrophy
por: Pan, Congbin, et al.
Publicado: (2022)

Beta3-Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress
por: Zhang, Mingming, et al.
Publicado: (2021)

Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene
por: Wang, Hu, et al.
Publicado: (2008)

Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats
por: Chang, Ruey-Lin, et al.
Publicado: (2019)

CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation
por: Huang, Jian, et al.
Publicado: (2022)

Central role for BRAF in cardiac hypertrophy: rethinking the pathological–physiological divide
por: Altara, Raffaele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e0qpu39q7b3rjh6rr9gmv95679